Pharmacist-physician collaboration in pain management practice

Authors

  • Jennifer M. Strickland, PharmD, BCPS
  • Angela Huskey, PharmD
  • David B. Brushwood, RPh, JD

DOI:

https://doi.org/10.5055/jom.2007.0017

Keywords:

pharmacist, pain management, collaborative practice

Abstract

Pain is one of the most common reasons patients seek out healthcare and management typically requires complex medication regimens. Pharmacists have become increasingly more involved in pain management. Historically, pharmacists and physicians have often had adversarial relationships because of regulatory influence. However, as medication experts, pharmacists can play a key role in optimizing outcomes in the management of pain and can be critical to the success of the medication regimen. Numerous opportunities for collaboration exist for pharmacists and physicians in various settings. One example is the VIGIL process, an effective risk management strategy that requires collaboration between pharmacists and physicians. The success of pharmacist-physician collaboration will depend on numerous factors, including strong physician and administrative support. A clear strategy and stepwise approach to developing a pain management pharmacist-physician collaborative practice is the key to its success. Once the collaboration is formalized, a management strategy should also be defined and should include regular chart review and regular feedback from the physician. Through physician-pharmacist collaboration, pain management outcomes can be optimized and risk can be managed.

Author Biographies

Jennifer M. Strickland, PharmD, BCPS

Lakeland Regional Medical Center, Lakeland, Florida.

Angela Huskey, PharmD

Hospice of the Florida Suncoast, Largo, Florida.

David B. Brushwood, RPh, JD

Professor of Pharmacy Health Care Administration, College of Pharmacy, The University of Florida, Gainesville, Florida.

References

Branding FH: The impact of controlled substance federal regulations on the practice of pharmacy. J Pharm Pract. 1995; 8: 130-137.

Brushwood DB: From confrontation to collaboration: Collegial accountability and the expanding role of pharmacists in the management of chronic pain. J Law Med Ethics. 2001; 29: 69-93.

21 C.F.R 1306.04.

Anon: Fisher’s ordeal finally is over: Last of four death suits dismissed. Available at http://www.cpmission.com/main/drfisher.html. Accessed December 20, 2007.

United States v. Hurwitz, 459 F.3d 463 (4th Cir. 2006).

Tierney J: A win for Dr. Hurwitz, a loss for the pill-counters. Available at http://tierneylab.blogs.nytimes.com/2007/07/13/a-win-for-dr-hurwitz-a-loss-for-the-pill-counters/. Accessed December 20, 2007.

Rosenberg T: When is a pain doctor a drug pusher? New York Times Magazine, June 17, 2007: 48-55.

Fisher L: Physician awarded $1.8M in Lawsuit. Available at http://www.painreliefnetwork.org/prn/physician-awarded- 18m-in-lawsuit.php. Accessed December 20, 2007.

Brushwood D: VIGIL: A regrettable necessity for opioid prescribing and dispensing. Available at http://www.painandthelaw.org/mayday/brushwood_071505.php. Accessed December 20, 2007.

Lee Y-P, Schommer JC: Effect of a pharmacist-managed anticoagulation clinic on warfarin-related hospital admissions. Am J Health Syst Pharm. 1996; 53: 1580-1583.

Wilt VM, Gums JG, Ahmed OI, et al.: Outcome analysis of a pharmacist-managed anticoagulation service. Pharmacotherapy. 1995; 15: 732-739.

Chiquette E, Amato MG, Bussey HI: Comparision of an anticoagulation clinic with usual medical care: Anticoagulation control, patient outcomes, and health care costs. Arch Intern Med. 1998; 158: 1641-1647.

Conte RR, Kohoe WA, Nielson N, et al.: Nine-year experience with a pharmacist-managed anticoagulation clinic. Am J Hosp Pharm. 1996; 43: 2460-2464.

Garabedian-Ruffalo SM, Gray DR, Sax MJ, et al.: Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic. Am J Hosp Pharm. 1985; 42: 304-308.

Leal SL, Herrier RN, Glover JJ, et al.: Improving Quality of care in diabetes through a comprehensive pharmacist-based disease management program. Diabetes Care. 2004; 27: 2893-2894.

Shane-McWhorter L, Oderda GM. Providing diabetes education and care to underserved patients in a collaborative proactice at a Utah community health center. Pharmacotherapy. 2005; 25(1): 96-109.

Kiel PJ, McCord AD: Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother. 2005; 39: 1828-1832.

Finley PR, Rens HR, Pont JT, et al.: Impact of a collaborative pharmacy practice model on the treatment of depression in primary care. Am J Health Syst Pharm. 2002; 59: 1518-1526.

Dole EJ, Murawski MM, Adolphe AB, et al.: Provision of pain management by a pharmacist with prescribing authority. Am J Health Syst Pharm. 2007; 64(1): 85-89.

Wong EY, Thompson MV, Dudgeon MA, et al.: Hospital pharmacy-based service for patient-controlled analgesia. Am J Hosp Pharm. 1990; 47(2): 364-369.

Berggren P, Matsuoka R: Pharmacy protocol for adjusting patient-controlled analgesia. Hosp Pharm. 1990; 25: 928-929, 932.

McCall LJ, Dierks DR: Pharmacy-managed patient-controlled analgesia service. Am J Hosp Pharm. 1990; 47: 2706-2710.

Lothian ST, Fotis MA, von Gunten CF, et al.: Cancer pain management through a pharmacist-based analgesic dosing service. Am J Health Syst Pharm. 1999; 56: 1119-1125.

Published

11/01/2007

How to Cite

Strickland, PharmD, BCPS, J. M., A. Huskey, PharmD, and D. B. Brushwood, RPh, JD. “Pharmacist-Physician Collaboration in Pain Management Practice”. Journal of Opioid Management, vol. 3, no. 6, Nov. 2007, pp. 295-01, doi:10.5055/jom.2007.0017.

Similar Articles

You may also start an advanced similarity search for this article.